Shibi Muralidar

679 total citations
6 papers, 434 citations indexed

About

Shibi Muralidar is a scholar working on Infectious Diseases, Neurology and Surgery. According to data from OpenAlex, Shibi Muralidar has authored 6 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Neurology and 1 paper in Surgery. Recurrent topics in Shibi Muralidar's work include COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Long-Term Effects of COVID-19 (2 papers). Shibi Muralidar is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Long-Term Effects of COVID-19 (2 papers). Shibi Muralidar collaborates with scholars based in India. Shibi Muralidar's co-authors include Senthil Visaga Ambi, Saravanan Sekaran, Uma Maheswari Krishnan, Thirumalai Diraviyam, P. Balamurugan and Selvaraj Vimalraj and has published in prestigious journals such as Life Sciences, International Journal of Biological Macromolecules and Biochimie.

In The Last Decade

Shibi Muralidar

5 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shibi Muralidar India	5	118	112	97	60	39	6	434
Jianxin Li China	12	103 0.9×	101 0.9×	44 0.5×	73 1.2×	40 1.0×	28	422
Peter H. Rheinstein United States	12	133 1.1×	139 1.2×	68 0.7×	40 0.7×	41 1.1×	89	612
Zhenting Huang China	10	43 0.4×	158 1.4×	97 1.0×	39 0.7×	22 0.6×	22	433
Kajal Rawat India	9	173 1.5×	146 1.3×	42 0.4×	30 0.5×	31 0.8×	21	480
Keren Asraf Israel	17	444 3.8×	109 1.0×	114 1.2×	51 0.8×	53 1.4×	36	928
Vandana Tiwari India	14	45 0.4×	79 0.7×	24 0.2×	29 0.5×	17 0.4×	75	528
Dymphy Huntjens Belgium	13	107 0.9×	93 0.8×	57 0.6×	139 2.3×	20 0.5×	28	609
Panpan Wang China	14	85 0.7×	142 1.3×	45 0.5×	61 1.0×	39 1.0×	51	531
Ігор Петрович Кайдашев Ukraine	11	53 0.4×	113 1.0×	99 1.0×	25 0.4×	18 0.5×	114	605

Countries citing papers authored by Shibi Muralidar

Since Specialization

Citations

This map shows the geographic impact of Shibi Muralidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibi Muralidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibi Muralidar more than expected).

Fields of papers citing papers by Shibi Muralidar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibi Muralidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibi Muralidar. The network helps show where Shibi Muralidar may publish in the future.

Co-authorship network of co-authors of Shibi Muralidar

This figure shows the co-authorship network connecting the top 25 collaborators of Shibi Muralidar. A scholar is included among the top collaborators of Shibi Muralidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibi Muralidar. Shibi Muralidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Muralidar, Shibi, et al.. (2023). The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy. International Journal of Biological Macromolecules. 242(Pt 1). 124771–124771. 14 indexed citations

2.

Muralidar, Shibi, et al.. (2023). Molecular basis of COVID-19, ARDS and COVID-19-associated ARDS: Diagnosis pathogenesis and therapeutic strategies. Biocell. 47(11). 2335–2350.

3.

Muralidar, Shibi, et al.. (2021). Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19. Journal of Medical Virology. 93(9). 5260–5276. 28 indexed citations

4.

Muralidar, Shibi, Senthil Visaga Ambi, Saravanan Sekaran, Thirumalai Diraviyam, & P. Balamurugan. (2020). Role of tau protein in Alzheimer's disease: The prime pathological player. International Journal of Biological Macromolecules. 163. 1599–1617. 177 indexed citations

5.

Muralidar, Shibi, Senthil Visaga Ambi, Saravanan Sekaran, & Uma Maheswari Krishnan. (2020). The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 179. 85–100. 197 indexed citations

6.

Sekaran, Saravanan, Senthil Visaga Ambi, Shibi Muralidar, et al.. (2020). Inflammation in myocardial injury- Stem cells as potential immunomodulators for myocardial regeneration and restoration. Life Sciences. 250. 117582–117582. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact